TEM (Tempus) Long-Term Debt

Brandmark of tempus.com (TEM)

Tempus AI, Inc (TEM) possesses unique medical data archives for which major pharma behemoths pay a premium price. The synergy of AI and genetics ensures a rapid increase in the accuracy of cancer therapy. Integration into clinics creates long-term subscription rent. The time series of the business's long-term debt demonstrates a financial burden, where 1.37 serves as the base parameter value.

TEM (Tempus) Company Long-Term Debt history from 06/15/2024 to 10/28/2026

Analytical breakdowns for tempus.com (TEM)

- price and consensus price forecast:
Price Tempus Labs|TEM - Analyst Consensus Forecast
- market capitalization data:
Market Value Tempus|TEM - Total Company Value
- book capitalization data:
Accounting Value per Share Tempus|TEM - Company Book Value|Market Capitalization to Net Assets tempus.com|TEM - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital Tempus AI, Inc|TEM - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Tempus|TEM - Company Total Debt|Debt to Net Assets Ratio Tempus|TEM - Company Long-Term Debts|Company Short-Term Debts Tempus
Comprehensive company analysis:TEM (Tempus AI, Inc.)
Manufactured products of Tempus

The rapid scaling of Tempus AI, Inc (TEM) within the precision medicine segment is reflected in the dynamics of the company's long-term liabilities. This indicator aggregates all credit obligations with a maturity exceeding twelve months. By analyzing the volume of borrowed capital, investors assess the balance between debt service costs and the efficiency of investments in AI analytics. Market consensus views moderate debt as a tool for expansion that precludes the risk of insolvency.

Who Tempus AI, Inc competes with

Amount of Long-Term Liabilities qiagen.com QGEN|IONS (Ionis) - Company Long-Term Debts|RGEN: Long-Term Debt|RNA (Avidity) - Company Long-Term Debt|CRSP (CRISPR) - Company Long-Term Liabilities|Company Long-Term Debt GeneDx Holdings Corp. WGS|Long-Term Liabilities ultragenyx.com (RARE)|Company Long-Term Liabilities BEAM|Company Long-Term Debts SRPT (Sarepta Therapeutics)|Company Long-Term Debt TWST|TXG - Long-Term Debt Volume|Company Long-Term Liabilities Intellia Therapeutics (NTLA)|STOK - Company Long-Term Loans and Borrowings|BLFS: Company Long-Term Debts|Wave Life Sciences Ltd (WVE) - Company Long-Term Debts|MAZE: Company Long-Term Debts|Long-Term Debt Volume Sionna Corp (SION)|Prime Medicine, Inc. (PRME) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings tayshagtx.com (TSHA)|Company Long-Term Debts QURE|MeiraGTx Holdings - Long-Term Debt Volume|Regenxbio (RGNX) - Company Long-Term Debt|SLDB - Company Long-Term Indebtedness|OCGN (Ocugen, Inc.) - Company Long-Term Debts|Company Long-Term Liabilities pacb.com|Benitec Biopharma (BNTC) - Company Long-Term Liabilities|Amount of Long-Term Liabilities Design Therapeutics Inc|Rocket Pharmaceuticals Inc - Company Long-Term Debts|Long-Term Debt FDMT (4D Molecular Corp)|Lexeo Therapeutics, Inc. - Company Long-Term Debt|Company Long-Term Liabilities Korro Bio Inc. KRRO|Editas Medicine (EDIT) - Company Long-Term Debts|SLN: Company Long-Term Indebtedness|Company Long-Term Debt proqr.com|Codexis (CDXS) - Company Long-Term Indebtedness|SGMO (Sangamo Therapeutics) - Company Long-Term Debts|Company Long-Term Debts Nautilus Biotechnology Inc (NAUT)|Company Long-Term Liabilities Metagenomi|Amount of Long-Term Liabilities Precision BioSciences Inc. (DTIL)|GBIO: Company Long-Term Debts|Boundless Bio Inc - Long-Term Debt|XCUR: Company Long-Term Debt|IMNN: Company Long-Term Liabilities|Company Long-Term Debt phiopharma.com (PHIO)|Long-Term Liabilities Mustang Bio|RNAZ (TransCode Therapeutics Inc.) - Company Long-Term Liabilities|Company Long-Term Debts BNGO|APDN (Applied DNA Sciences) - Company Long-Term Debt|Long-Term Debt Volume bluebirdbio.com BLUE|Company Long-Term Liabilities ImmunoPrecise Antibodies Ltd.|Company Long-Term Loans and Borrowings Omega Therapeutics Inc OMGA|Singular Genomics Systems Inc - Company Long-Term Debts|RGLS - Company Long-Term Debts|Syros Pharmaceuticals - Company Long-Term Debts|Long-Term Debt Volume telesisbio.com|TCON - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Unity Biotechnology Inc.